HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...

Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with ...

Fintel reports that on February 13, 2025, UBS initiated coverage of Celldex Therapeutics (NasdaqCM:CLDX) with a Buy ...

Hope Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced engagement of BTIG, a leading global financial services ...

"We are pleased to engage with BTIG to build our HOPE network ... MD MPH and Matthew Duffy, Co-CEOs of HOPE Therapeutics. "BTIG is exceptionally well positioned to propel HOPE to achieve our ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.86, a high estimate of $14.00, ...

Q4 2024 Earnings Call Transcript February 7, 2025 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.12 ...

LAVA Therapeutics (NASDAQ:LVTX – Get Free Report)’s share price traded down 4.6% during mid-day trading on Wednesday . The stock traded as low as $0.93 and last traded at $0.94. 38,737 shares changed ...

Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment ContinuesPromising Data, including a 59% Stable ...